A Study of Camrelizumab Combined With Chemotherapy Sequential Camrelizumab Combined With Apatinib Treatment of Advanced NSCLC
Clinical trial NCT04950400 · UNKNOWN
Trial details
- NCT number
- NCT04950400
- Sponsor
- Beijing Chest Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2023-12-12
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.